A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the only vaccine for humans against Lyme disease. “Lyme disease can cause potentially serious consequences – where individuals and families face…
Lyme disease vaccine 70 percent effective: Pfizer
Originally reported by The Hill
Related Articles
Pentagon Officials Weigh Deployment of Airborne Troops for Iran War
The combat forces would come from a brigade of about 3,000 soldiers capable of deploying anywhere in the world within 18...
Watch live: Fatal LaGuardia crash news conference
Transportation Secretary Sean Duffy and Federal Aviation Administrator Bryan Bedford will address reporters on Monday af...
Senate Republican defends spending $200B on Iran war as an ‘America First’ priority
Sen. Jim Banks (R-Ind.) on Sunday defended a $200 billion funding request price tag for the U.S. conflict against Iran, ...
Trump tells lawmakers ‘don’t worry about Easter’ to force vote on DHS, SAVE Act
President Trump told Republican lawmakers on Monday to not “worry about Easter” in order to stay in Washington to vote o...